Letters SSRIs and tamoxifen

Authors’ reply

BMJ 2010; 340 doi: http://dx.doi.org/10.1136/bmj.c1321 (Published 10 March 2010) Cite this as: BMJ 2010;340:c1321
  1. Frank Andersohn, senior research associate1,
  2. Stefan N Willich, professor and director1
  1. 1Institute for Social Medicine, Epidemiology, and Health Economics, Charité University Medical Centre, 10098 Berlin, Germany
  1. frank.andersohn{at}charite.de

    Our recommendations and those of others (full reference details of which are available in the response on bmj.com) to avoid coprescribing fluoxetine and tamoxifen are not based on a hypothesis alone, as indicated by Jenkinson,1 2 but on the growing evidence of a central role for cytochrome P450 2D6 …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial